Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors
Carlotta Granchi, Flavio Rizzolio, Stefano Palazzolo, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 22, pp. 10299-10314
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders
Hui Deng, Weimin Li
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 4, pp. 582-602
Open Access | Times Cited: 139
Monoacylglycerol lipase (MAGL) as a promising therapeutic target
Ana Gil-Ordóñez, Mar Martín‐Fontecha, Silvia Ortega‐Gutiérrez, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 18-32
Closed Access | Times Cited: 103
Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation
Laura A. McAllister, Christopher R. Butler, Scot Mente, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 7, pp. 3008-3026
Closed Access | Times Cited: 66
Structure-based molecular modeling in SAR analysis and lead optimization
Veronika Temml, Zsófia Kutil
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 1431-1444
Open Access | Times Cited: 43
4,4-Dimethylsterols Reduces Fat Accumulation via Inhibiting Fatty Acid Amide Hydrolase In Vitro and In Vivo
Tao Zhang, Liangliang Xie, Yiwen Guo, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 7
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017)
Carlotta Granchi, Isabella Caligiuri, Filippo Minutolo, et al.
Expert Opinion on Therapeutic Patents (2017) Vol. 27, Iss. 12, pp. 1341-1351
Closed Access | Times Cited: 58
Design, Synthesis, and Evaluation of Piperazinyl Pyrrolidin-2-ones as a Novel Series of Reversible Monoacylglycerol Lipase Inhibitors
Jumpei Aida, Makoto Fushimi, Tomokazu Kusumoto, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 20, pp. 9205-9217
Closed Access | Times Cited: 58
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor
Carlotta Granchi, Margherita Lapillo, Sandra Glasmacher, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 4, pp. 1932-1958
Open Access | Times Cited: 53
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors
Mojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Stefania Baraldi, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 3, pp. 1340-1354
Open Access | Times Cited: 51
Identification of a Possible Endocannabinoid-Mediated Mechanism of Action of Cetylated Fatty Acids
Giulia Bononi, Carlotta Granchi, Tiziano Tuccinardi, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 363-363
Open Access
Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
Carlotta Granchi, Giulia Bononi, Rebecca Ferrisi, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112857-112857
Open Access | Times Cited: 34
Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl Moiety
Shuhei Ikeda, Hideyuki Sugiyama, Hidekazu Tokuhara, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 15, pp. 11014-11044
Open Access | Times Cited: 28
Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
Anca Zanfirescu, Anca Ungurianu, Dragoș Paul Mihai, et al.
Molecules (2021) Vol. 26, Iss. 18, pp. 5668-5668
Open Access | Times Cited: 27
Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives
Giulia Bononi, Miriana Di Stefano, Giulio Poli, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 10, pp. 7118-7140
Open Access | Times Cited: 19
Steatosis in metabolic diseases: A focus on lipolysis and lipophagy
Xingtao Zhao, Felix Kwame Amevor, Zhifu Cui, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114311-114311
Open Access | Times Cited: 12
Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors
Giulia Bononi, Carlotta Granchi, Margherita Lapillo, et al.
European Journal of Medicinal Chemistry (2018) Vol. 157, pp. 817-836
Open Access | Times Cited: 34
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
Giulio Poli, Margherita Lapillo, Vibhu Jha, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2019) Vol. 34, Iss. 1, pp. 589-596
Open Access | Times Cited: 34
An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)
Giulia Bononi, Giulio Poli, Flavio Rizzolio, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 31, Iss. 2, pp. 153-168
Closed Access | Times Cited: 31
Discovery of a novel class of reversible monoacylglycerol lipase inhibitors for potential treatment of depression
Qingjing Hao, Junwei Shi, Zhilan Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116285-116285
Closed Access | Times Cited: 3
Structure-Guided Discovery of cis-Hexahydro-pyrido-oxazinones as Reversible, Drug-like Monoacylglycerol Lipase Inhibitors
Bernd Kuhn, Martin Ritter, Benoit Hornsperger, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors
Carlotta Granchi, Isabella Caligiuri, Eleonora Bertelli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2017) Vol. 32, Iss. 1, pp. 1240-1252
Open Access | Times Cited: 31
Anticancer Potential of Small‐Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase
Shivani Jaiswal, Senthil Raja Ayyannan
ChemMedChem (2021) Vol. 16, Iss. 14, pp. 2172-2187
Closed Access | Times Cited: 20
Discovery of Aryl Formyl Piperidine Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase Inhibitors
Zhuoer Zhi, Wenting Zhang, Jingchun Yao, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 11, pp. 5783-5796
Closed Access | Times Cited: 18
Novel Reversible-Binding PET Ligands for Imaging Monoacylglycerol Lipase Based on the Piperazinyl Azetidine Scaffold
Jian Rong, Wakana Mori, Xiaotian Xia, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 19, pp. 14283-14298
Open Access | Times Cited: 16
Development of a highly-specific 18F-labeled irreversible positron emission tomography tracer for monoacylglycerol lipase mapping
Zhen Chen, Wakana Mori, Jian Rong, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 6, pp. 1686-1695
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top